Rheanne Whitham
About Rheanne Whitham
Rheanne Whitham is the Manager of Production Planning and Scheduling Cell Therapy at Bristol Myers Squibb in the United States, with extensive experience in the biotechnology industry.
Title and Current Role at Bristol Myers Squibb
Rheanne Whitham currently holds the position of Manager, Production Planning and Scheduling Cell Therapy at Bristol Myers Squibb in the United States. In this role, she is responsible for overseeing production planning and scheduling within the cell therapy domain, leveraging her extensive experience in the field.
Previous Roles at Bristol Myers Squibb
Before assuming her current position, Rheanne Whitham served as the CAR-T Clinical Manufacturing Supervisor at Bristol Myers Squibb from 2020 to 2022 in Warren County, New Jersey. During her tenure, she focused on clinical manufacturing of CAR-T cell therapy products, gaining significant hands-on experience in cGMP environments.
Experience at RoslinCT
Rheanne Whitham worked as the Lead Production Scientist: Logistics at RoslinCT in Edinburgh, United Kingdom, from 2019 to 2020. In this role, she oversaw logistics related to production, demonstrating her strengths in process improvement and employee engagement.
Career at Lonza Netherlands
From 2018 to 2019, Rheanne Whitham was employed as the Team Leader: Cell Therapy Manufacturing at Lonza Netherlands, formerly PharmaCell, located in the Maastricht Area, Netherlands. She led a team focusing on cell therapy manufacturing, bringing her expertise in cell-based assays and cell culture to the forefront.
Academic Background
Rheanne Whitham completed her BSc (Hons) in Animal Biology from The University of Stirling, where she studied from 2008 to 2012. This academic foundation provided a strong grounding in biological sciences, which she has applied throughout her career in the biotechnology industry.